Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
about
Characterization of rabbit myocilin: Implications for human myocilin glycosylation and signal peptide usageCurrent concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatmentAnimal models of glucocorticoid-induced glaucomaA Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA SequencingThe variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomyLittle evidence for association of the glaucoma gene MYOC with open-angle glaucoma.Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.MYOC and FOXC1 gene analysis in primary congenital glaucoma.The effect of temperature on gene silencing by siRNAs: implications for silencing in the anterior chamber of the eye.Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular HypertensionGene expression changes in steroid-induced IOP elevation in bovine trabecular meshwork.Higher incidence of steroid-induced ocular hypertension in keratoconusComprehensive analysis of myocilin variants in east Indian POAG patients.Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis.Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes.Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-consanguineous congenital forms in a Spanish population.Intraocular pressure following intravitreal injection of triamcinolone acetonide.Glaucoma genetics.Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma.Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma.Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.Glucocorticoid therapy and ocular hypertension.Model systems for the study of steroid-induced IOP elevation.Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.Steroid-induced Glaucoma: An Avoidable Irreversible Blindness.Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork.Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.Outcome of Primary Nonpenetrating Deep Sclerectomy in Patients with Steroid-Induced Glaucoma.Retina and glaucoma: surgical complications
P2860
Q24799202-F518D915-6CBE-4E28-AB09-2DB101CCB75FQ27015027-130204F9-8F81-4824-9EB5-FA2707A440C9Q28085360-4257F204-88D7-459C-A1BA-0CF44CBFEAA0Q28469378-CB259A09-9B18-4B7E-8AF2-C31F0137E69AQ33287406-70168D09-B72B-4885-ACAB-EFA300A4BDEBQ33446334-44401D2E-D301-41E9-910D-DAADE45C7867Q34020747-6F887B88-5B5E-4ECA-B8B9-B0A5ED25EB64Q34208364-40D3614F-5C6F-4864-A436-31D08EA59893Q34719249-86731771-F2FE-46FC-A389-986459022741Q35522213-5203B91A-AC6E-41BF-9002-2F80912E4401Q35560469-C974C7D0-279F-4A80-B08A-9F06B97E7CD3Q35591485-56709F7F-D6E2-448A-A4F1-6CB86BB29869Q35933577-07949FC1-9625-4D74-92EF-7BAE6D0A6153Q36051583-088E564E-CB99-4F3C-89B3-669B3193885BQ36173241-32E0443D-1061-499B-842E-40B79405DEF3Q36354205-CF883A35-0AF8-45CA-A51A-3B09359D577EQ36620648-821C3577-E732-46CA-BA5E-15D041857920Q37059858-F7DA47C4-AC65-4E57-B20C-897333B13369Q37071359-DD0593D9-A106-44D5-A1CD-6B85FC9ED1A9Q37223023-0D1E6C19-3E21-4F4C-A67E-1C02ACA51FCAQ37303762-4B740BA6-B338-4CE5-B13B-9CF3C97949C0Q37527287-004F4945-FEE7-4168-9A30-DFB534F711C5Q37726620-24AFEA4F-B911-454A-858A-2BE9469A8E6AQ38186084-E7E50199-AE99-49DC-8935-640F797C9EDAQ38889124-69926CA7-1577-4564-8B4D-69F62324EDBEQ38906581-0EDFEC09-3F0F-4313-854F-FE7C8B5DD591Q38963936-847A2080-65FA-4082-8D60-1AF9242CBE4BQ41564468-1F131C21-18D3-488D-A339-2AA95B175C30Q44560624-F6532689-6C95-43C4-B6C3-E0FE002E0FAAQ47333845-BFD4A44D-4D9A-4A8D-BB55-A227EE967DFEQ55097449-7E504246-0E51-4124-83DB-BA009E6D2CBAQ58763782-C020E94B-14B4-4823-BE1E-1C7724C2EABA
P2860
Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@ast
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@en
type
label
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@ast
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@en
prefLabel
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@ast
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@en
P2093
P1476
Evaluation of the myocilin (MY ...... d-induced ocular hypertension.
@en
P2093
Fingert JH
McLaughlin M
Sheffield VC
Snibson GR
P304
P407
P577
2001-01-01T00:00:00Z